just saw that aquestive therapeutics brought in matthew greenhawt as their new cmo. guy's got serious credentials in allergy and immunology - was running things at the asthma and allergy foundation before this. also spent time as a pediatrics prof at childrens hospital colorado, so he knows his stuff when it comes to patient-centered care and health policy. replacing the interim cmo gary slatko. interesting move for them, especially if they're pushing into the allergy space more aggressively. matthew's background in food allergy and anaphylaxis research could be pretty valuable there. stock was up a bit on the news. anyone else following aquestive?